Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2025-02-28 00:00:00 ET · period of report 2025-02-26 · accession 0001055726-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-28 | 2025-02-26 | INO | Humeau Laurent | CSO | F - Tax | $1.98 | -3,643 | 29.6K | -11% | -$7,213 |
| DM | 2025-02-28 | 2025-02-26 | INO | Humeau Laurent | CSO | M - OptEx | — | +8,865 | 31.6K | +39% | — |
| DM | 2025-02-28 | 2025-02-26 | INO | Humeau Laurent | CSO | M - OptEx | $0.00 | -8,865 | 0 | -100% | $0 |
| DM | 2025-02-28 | 2025-02-27 | INO | Humeau Laurent | CSO | A - Grant | $0.00 | +49.5K | 22.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-26 | F | D | 1,584 | $1.98 | 26,608 | D | — | — | (F2) The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. |
| 2 | Common | Common Stock | 2025-02-26 | M | A | 3,855 | — | 28,192 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,566 restricted stock units granted on February 26, 2022 was as follows: 3,855 shares vested on February 26, 2023; 3,856 shares vested on February 26, 2024; and 3,855 shares vested on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 3 | Common | Common Stock | 2025-02-26 | F | D | 2,059 | $1.98 | 29,559 | D | — | — | (F4) The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein. |
| 4 | Common | Common Stock | 2025-02-26 | M | A | 5,010 | — | 31,618 | D | — | — | (F3) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 is as follows: 5,010 shares vested on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 5 | Derivative | Restricted Stock Unit | 2025-02-26 | M | D | 5,010 | $0.00 | 10,019 | D | — · — to — | 5,010 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 is as follows: 5,010 shares vested on February 26, 2025; 5,010 shares will vest on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 6 | Derivative | Restricted Stock Unit | 2025-02-26 | M | D | 3,855 | $0.00 | 0 | D | — · — to — | 3,855 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 11,566 restricted stock units granted on February 26, 2022 was as follows: 3,855 shares vested on February 26, 2023; 3,856 shares vested on February 26, 2024; and 3,855 shares vested on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 7 | Derivative | Common Stock Option | 2025-02-27 | A | A | 27,402 | $0.00 | 27,402 | D | $1.94 · 2025-02-27 to 2035-02-27 | 27,402 Common Stock | (F5) The vesting schedule for the 27,402 options is as follows: 13,701 shares vested on February 27, 2025 and 13,701 shares will vest on February 26, 2026. |
| 8 | Derivative | Restricted Stock Unit | 2025-02-27 | A | A | 22,098 | $0.00 | 22,098 | D | — · — to — | 22,098 Common Stock | (F6) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 22,098 restricted stock units granted on February 27, 2025 is as follows: 7,366 shares will vest on February 26, 2026; 7,366 shares will vest on February 26, 2027; and 7,366 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |